Clinical trials
Phase 1/2 Glucose Metabolism Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diva De Leon | 1 |
| ModernaTX, Inc. | 1 |
| Otsuka Pharmaceutical Factory, Inc. | 1 |
| Seraxis | 1 |
| Ultragenyx Pharmaceutical Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 5 |
| Hypoglycemia | 3 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Glycogen Storage Disease Type I | 2 |
| Metabolic Diseases | 2 |
| Autoimmune Diseases | 1 |
| Congenital Hyperinsulinism | 1 |
| Endocrine System Diseases | 1 |
| Genetic Diseases, Inborn | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.